Bellevue Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Hold |
100
| – | – | 0.01% | 262 |
|
|
2025
Q1 | $14.7K | Hold |
100
| – | – | 0.01% | 252 |
|
|
2024
Q4 | $13K | Hold |
100
| – | – | 0.01% | 266 |
|
|
2024
Q3 | $15.6K | Hold |
100
| – | – | 0.01% | 252 |
|
|
2024
Q2 | $15.6K | Hold |
100
| – | – | 0.01% | 242 |
|
|
2024
Q1 | $13.7K | Hold |
100
| – | – | 0.01% | 244 |
|
|
2023
Q4 | $13.4K | Hold |
100
| – | – | 0.01% | 249 |
|
|
2023
Q3 | $13.5K | Hold |
100
| – | – | 0.01% | 242 |
|
|
2023
Q2 | $14.4K | Hold |
100
| – | – | 0.01% | 244 |
|
|
2023
Q1 | $14K | Hold |
100
| – | – | 0.01% | 250 |
|
|
2022
Q4 | $13.6K | Hold |
100
| – | – | 0.01% | 255 |
|
|
2022
Q3 | $11K | Hold |
100
| – | – | 0.01% | 271 |
|
|
2022
Q2 | $13K | Hold |
100
| – | – | 0.01% | 271 |
|
|
2022
Q1 | $13K | Hold |
100
| – | – | 0.01% | 295 |
|
|
2021
Q4 | $12K | Hold |
100
| – | – | 0.01% | 312 |
|
|
2021
Q3 | $12K | Hold |
100
| – | – | 0.01% | 319 |
|
|
2021
Q2 | $12K | Hold |
100
| – | – | 0.01% | 320 |
|
|
2021
Q1 | $10K | Hold |
100
| – | – | 0.01% | 352 |
|
|
2020
Q4 | $11K | Hold |
100
| – | – | 0.01% | 338 |
|
|
2020
Q3 | $11K | Buy |
+100
| New | +$11K | 0.01% | 316 |
|